These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37037766)

  • 21. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
    Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
    BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative CT features for characterization of vessels that encapsulate tumor clusters in hepatocellular carcinoma.
    Liu Z; Mao Y; Liu L; Li J; Li Q; Zhou Y
    Eur J Radiol; 2024 Oct; 179():111681. PubMed ID: 39142009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
    Tian Y; Lyu H; He Y; Kanduri HK
    J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor burden in patients with early and intermediate-stage hepatocellular carcinoma undergoing liver resection: a retrospective multicenter study on clinical and oncological outcomes.
    Martin D; Smet H; Da Silva Costa AC; Halkic N; Uldry E; Tabrizian P; Schwartz M; Mahamid A; Goumard C; Scatton O; Perinel J; Adham M; Demartines N; Melloul E
    HPB (Oxford); 2023 Jul; 25(7):836-844. PubMed ID: 37098458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 27. The prognostic value of vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang M; Cao L; Wang Y; Huang H; Tian X; Lei J
    Clin Transl Oncol; 2024 Aug; 26(8):2037-2046. PubMed ID: 38523240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.
    Wang YY; Zhong JH; Xu HF; Xu G; Wang LJ; Xu D; Wang HW; Wang K; Xiang BD; Mao YL; Li LQ; Xing BC
    Aliment Pharmacol Ther; 2019 Jan; 49(2):202-210. PubMed ID: 30506713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
    J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma.
    Wang JH; Li XS; Tang HS; Fang RY; Song JJ; Feng YL; Guan TP; Ruan Q; Wang J; Cui SZ
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4163-4172. PubMed ID: 36050540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma.
    Tsilimigras DI; Hyer JM; Diaz A; Moris D; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    J Surg Oncol; 2021 Feb; 123(2):381-388. PubMed ID: 33174627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
    Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
    Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective therapeutic options for elderly patients with hepatocellular carcinoma: A nationwide cohort study.
    Shin J; Yu JH; Jin YJ; Suh YJ; Kim DH; Byun S; Lee JW
    Medicine (Baltimore); 2019 Jul; 98(30):e16150. PubMed ID: 31348228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
    Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
    Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
    Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
    Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.
    Lin W; Lu L; Zheng R; Yuan S; Li S; Ling Y; Wei W; Guo R
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17231-17239. PubMed ID: 37801135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number.
    Hu XS; Yang HY; Leng C; Zhang ZW
    World J Gastroenterol; 2022 Nov; 28(44):6271-6281. PubMed ID: 36504552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.
    Renne SL; Woo HY; Allegra S; Rudini N; Yano H; Donadon M; Viganò L; Akiba J; Lee HS; Rhee H; Park YN; Roncalli M; Di Tommaso L
    Hepatology; 2020 Jan; 71(1):183-195. PubMed ID: 31206715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monofocal hepatocellular carcinoma: How much does size matter?
    Pelizzaro F; Penzo B; Peserico G; Imondi A; Sartori A; Vitale A; Cillo U; Giannini EG; Forgione A; Ludovico Rapaccini G; Di Marco M; Caturelli E; Zoli M; Sacco R; Cabibbo G; Marra F; Mega A; Morisco F; Gasbarrini A; Svegliati-Baroni G; Giuseppe Foschi F; Olivani A; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Oliveri F; Trevisani F; Farinati F;
    Liver Int; 2021 Feb; 41(2):396-407. PubMed ID: 33155401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.